Dual epitope anti-LILRB4 synthetic T-cell receptor and antigen receptor (STAR)-T-cell therapy for relapsed/refractory acute myeloid leukemia
Lv Meng, Zheng Hongli, Pei Xuying, Lei Lei, Chen Wenbo, Bao Yutong, Ding Yiyang, Xu Zhengli, Hu Lijuan, Wan Zhe, Zhao Xueqiang, Zhou Zhixiao, Lin Xin, Huang Xiaojun, Wang Jiasheng, Zhao Xiangyu
Journal：Signal Transduction and Targeted Therapy
IF：81.2
DOI：10.1038/s41392-026-02765-7
PMID：
Published：2026-06-01
research field：肿瘤学分子生物学免疫治疗血液学临床试验
Abstract
本文使用的Yeasen产品
相关产品
